Erinacine E as a Kappa Opioid Receptor Agonist and Its New Analogs from a Basidiomycete, Hericium ramosum
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-11-25
著者
-
Suzuki Y
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Kim Y
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Kojima Yasuhiro
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Kim Yoon
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Saito Toshiyuki
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Suzuki Yumiko
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
SMOGOWICZ Adam
Central Research Division, Pfizer Inc.
-
WONG John
Central Research Division, Pfizer Inc.
-
SAKEMI Shinichi
Exploratory Medicinal Sciences, PGRD, Nagoya Laboratories, Pfizer Pharmaceuticals, Inc.
-
Saito Tatsuhiro
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
SAITO Toshiyuki
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
AOKI Fukumatsu
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
HIRAI Hideo
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
INAGAKI Taisuke
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
MATSUNAGA Yasue
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
SAKAKIBARA Tatsuo
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
SAKEMI Shinichi
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
SUZUKI Yumiko
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
WATANABE Shuzo
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
SUGA Osamu
Medicinal Biology Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
SUJAKU Tetsujo
Medicinal Biology Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
TRUESDELL Susan
Central Research Division, Pfizer Inc.
-
NAGAHISA Atsushi
Medicinal Biology Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
KOJIMA Yasuhiro
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
KOJIMA Nakao
Natural Product & Lead Discovery Laboratory Central Research Division, Pfizer Pharmaceuticals Inc.
-
Inagaki Taisuke
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Matsunaga Yasue
Exploratory Medicinal Sciences And Discovery Pharmacology I Pgrd Nagoya Laboratories Pfizer Pharmace
-
Truesdell Susan
Bioprocess Research & Development Pfizer Global Research And Development(pgrd)-groton Laboratori
-
Sugiura Ayumu
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Watanabe Shuzo
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Sujaku Tetsujo
Exploratory Medicinal Sciences And Discovery Pharmacology I Pgrd Nagoya Laboratories Pfizer Pharmace
-
Sakemi Shinichi
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Wong John
Bioprocess Research & Development Pfizer Global Research And Development(pgrd)-groton Laboratori
-
Suga Osamu
Exploratory Medicinal Sciences And Discovery Pharmacology I Pgrd Nagoya Laboratories Pfizer Pharmace
-
Hirai Hideo
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Hirai Hideo
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Kojima Nakao
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Kojima Nakao
Faculty Of Pharmacy Meijo University
-
Kojima Nakao
Central Research Division Pfizer Pharmaceuticals Inc.
-
Sugie Yutaka
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Shiomi Yukio
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Akio Fukumatsu
Natural Product & Lead Discovery Laboratory Central Research Division Pfizer Pharmaceuticals Inc
-
Smogowicz Adam
Central Research Division Pfizer Inc.
-
Sakakibara Tatsuo
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Smogowicz Adam
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Sakemi Shinichi
Central Research Division Pfizer Pharmaceuticals Inc.
-
Nagahisa Atsushi
Central Research Pfizer Pharmaccuticals Inc
-
Kato Yoshinao
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Kim Yoon-jeong
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
関連論文
- Preparation of Oligoselenodiglutathiones and Their Suppressive Effects on Oxidative DNA Damage Induced by Catechol and Copper
- Towards Structural Determination of the ComX Pheromone : Synthetic Studies on Peptides Containing Geranyltryptophan
- Production of Tuberactinamine A by Streptomyces griseoverticillatus var. tuberacticus NRRL 3482 Fed with (S)-2-Aminoethyl-L-cysteine
- Fredericamycin A Affects Mitochondrial Inheritance and Morphology in Saccharomyces cerevisiae
- Construction of a Bacterial Artificial Chromosome Library for a Myxobacterium of the Genus Cystobacter and Characterization of an Antibiotic Biosynthetic Gene Cluster
- Biotransformation of Cystothiazole A, a Myxobacterial Antibiotic, into Novel Derivatives by the Mother Producer, Cystobacter fuscus
- Biosynthetic Studies on a Myxobacterial Antibiotic, Cystothaiazole A: Biosynthetic Precursors of the Carbon Skeleton
- New Cyclic Depsipeptide Antibiotics, Clavariopsins A and B, Produced by an Aquatic Hyphomycetes, Clavariopsis aquatica : 2. Structure Analysis
- New Cyclic Depsipeptide Antibiotics, Clavariopsins A and B, Produced by an Aquatic Hyphomycetes, Clavariopsis aquatica : 1. Taxonomy, Fermentation, Isolation, and Biological Properties
- Cystothiazoles A and B, New Bithiazole-type Antibiotics from the Myxobacterium Cystobacter fuscus
- (1-Benzylinodole-3-yl)alkanoic Acids : Novel Nonsteroidal Inhibitors of Steroid 5α-Reductase (I)
- CJ-21,058, a New SecA Inhibitor Isolated from a Fungus
- CJ-15,801, a Novel Antibiotic from a Fungus, Seimatosporium sp.
- New Pyrrolizidinone Antibiotics CJ-16,264 and CJ-16,367
- A Novel Antibiotic CJ-17,572 from a Fungus, Pezicula sp.
- A New Antibiotic CJ-17,665 from Aspergillus ochraceus
- CJ-15,208, a Novel Kappa Opioid Receptor Antagonist from a Funguns, Ctenomyces serratus ATCC15502
- CJ-21, 164, a New D-Glucose-6-phosphate Phosphohydrolase Inhibitor Produced by a Fungus Chloridium sp.
- CJ-15,696 and Its Analogs, New Furopyridine Antibiotics from the Fungus Cladobotryum varium : Fermentation, Isolation, Structural Elucidation, Biotransformation and Antibacterial Activities
- Cytokine Production Inhibitors Produced by a Fungus, Oidiodendron griseum
- Novel Cytokine Production Inhibitors Produced by a Basidiomycete, Marasmiellus sp.
- CJ-13,981 and CJ-13,982, New Squalene Synthase Inhibitors
- New Quinolone Compounds from Pseudonocardia sp. with Selective and Potent Anti-Helicobacter pylori Activity: Taxonomy of Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities
- CJ-12, 373, a Novel Topoisomerase II Inhibitor: Fermentation, Isolaton, Atructure Elucidation and Biological Activities
- Novel Lactone Compounds from Mortierella verticillata that Induce the Human Low Density Lipoprotein Receptor Gene: Fermentation, Isolation, Structural Elucidation and Biological Activities
- CJ-12, 954 and Its Congeners, New Abti-Helicobacter pylori Compounds Produced by Phanerochaete velutina: Fermentation, Isolation, Structural Elucidation and Biological Activities
- Generation of Novel Rapamycin Structures by Microbial Manipulations
- CJ-12, 371 and CJ-12, 372, Two Novel DNA Gyrase Inhibitors Fermentation, Isolation, Structural Elucidation and Biological Activities
- Thielavins as Glucose-6-phosphatase (G6Pase) Inhibitors : Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities
- Erinacine E as a Kappa Opioid Receptor Agonist and Its New Analogs from a Basidiomycete, Hericium ramosum
- Novel Cephalosporins Having a Benzothiopyran Group 2.Synthesis and Biological Activity of Catecholic Benzothiopyran Group at the C-3 Side Chain
- Novel Cephalosporins Having a Benzothiopyran Group 1.Synthesis and Antibacterial Activity of Cephalosporin Derivatives Characterized by Novel C-3 Substituents of Benzothiopyran
- Regulation of Tumor Necrosis Factor-α Production by a Fungal Metabolite, PR 1388
- CJ-15,183, a New Inhibitor of Squalene Synthase Produced by a Fungus, Aspergillus aculeatus
- Production of Polyselenodipenicillamines, Unique Selenium Compounds
- Involvement of DNA Conformational Change Induced by Rearrangement of Copper-coordination Geometry in Oxidative DNA Damages Caused by Copper and Dopamine
- Formation of DNA Damaging Product from Light-Irradiated Nonylphenol
- Novel Estrogenic Microsomal Metabolites from Phthalate Esters
- Phthalate Esters Detected in Various Water Samples and Biodegradation of the Phthalates by Microbes Isolated from River Water
- CJ-19,784, a New Antifungal Agent from a Fungus, Acanthostigmella sp.
- Erinacines E, F, and G, Stimulators of Nerve Growth Factor (NGF)-Synthesis, from the Mycelia of Hericium erinaceum.
- Structural Requirement of Nociceptive Peptide Nociceptin : Structural Importance of C-Terminal Fragment for Receptor Recognition
- Structure-Activity Relationships of a Naturally Occurring Nociceptive Peptide, Nociceptin
- Effects of Substitution of Hydrophobic Amino Acids by Tryptophan on Receptor Binding and Biological Activity of Neuropeptide Nociceptin
- Combined Effects of Manganese, Iron, Copper, and Dopamine on Oxidative DNA Damage
- Anti-Estrogenic Activity of Prenylated Isoflavones from Millettia pachycarpa : Implications for Pharmacophores and Unique Mechanisms
- Structural Requirements in Activation of Opioid Receptor-Like ORL1 Receptor by Nociceptin
- Transesterification in the Microbial Degradation of Phthalate Esters
- Potential Risks of Phthalate Esters: Acquisition of Endocrine-disrupting Activity during Environmental and Metabolic Processing